Michael P Dube insider trades

Open-market stock purchases and sales by Michael P Dube, VP, Chief Accounting Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2024.

Recent trades

DateStockTradeValue
Jul 1, 2026NTLA Intellia Therapeutics, IncSold$44.3K
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$27.5K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 6 sales, last Jul 1, 2026

Get free alerts when Michael P Dube files a new trade →